OpenAlex
PricingAboutJobs
Log inGet started
Work

Co-occurring gene alterations associated with efficacy of osimertinib in EGFR-mutated lung cancer: Based on a large-scale genomic screening project (LC-SCRUM-Asia).

HTML

Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2022.40.16_suppl.9103
Authors: Yuji Shibata, Shingo Matsumoto, Shunta Mori, Tetsuya Sakai, Hiroki Izumi, Hibiki Udagawa, Kaname Nosaki, Yoshitaka Zenke, Kiyotaka Yoh, Haruko Daga, Atsuhisa Tamura, Jun Sakakibara-Konishi, Shoichi Kuyama, Naoki Furuya, Atsushi Nakamura, Masato Shingyoji, Kazumi Nishino, Terufumi Kato, Susumu Kobayashi, Koichi Goto
Institutions: National Cancer Center Hospital East, Osaka City General Hospital, Tokyo National Hospital, Hokkaido University Hospital, Iwakuni Medical Center, St. Marianna University School of Medicine, Sendai Kousei Hospital, Chiba Cancer Center, Osaka International Cancer Institute, Kanagawa Cancer Center
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: osimertinib, EGFR-mutant non-small cell lung cancer, tumor mutational burden, L858R mutation, compound EGFR mutations, FGFR1, RET, MET, progression-free survival, predictive biomarkers
SDG: Good health and well-being

Open Access status: closed

Funder: Japan Agency for Medical Research and Development
OpenAlex ID: W4281908453
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms